Hormonal contraceptives market expected to reach USD 23.75 billion by 2032.

From GlobeNewswire: 2025-06-03 09:05:00

The Hormonal Contraceptives Market was estimated at USD 16.77 billion in 2023, expected to reach USD 23.75 billion by 2032, with a growth rate of 4.49%. Factors driving growth include increased awareness of family planning, demand for effective birth control, and advancements in drug delivery systems. The US leads the North American market, with a CAGR of 4.03% from 2024-2032. Hormonal implants are expected to register the fastest growth due to their long-acting efficacy and increasing availability in developing regions. The combined hormone contraceptives segment dominated the market in 2024, with a 74.56% market share, due to their high effectiveness and cycle-regulating advantages. Hospital pharmacies led the market with a 79.02% market share in 2024. North America dominates the market, while Asia-Pacific is expected to register the fastest growth. Major players in the market include Bayer AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. SNS Insider is a leading market research and consulting agency providing clients with current market data, consumer insights, and opinions to make confident decisions.



Read more at GlobeNewswire: Hormonal Contraceptives Market Size to Hit USD 23.75